灵活的参数加速失效时间模型与治愈
Birzhan Akynkozhayev1, Benjamin Christoffersen1, Xingrong Liu2
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Biometrical journal. Biometrische Zeitschrift
|September 10, 2025
概括
加速失效时间 (AFT) 模型为考克斯模型提供了一个可折叠和可解释的替代方案. 增强的AFT模型通过结合时间变化的效应和治愈模型来改善临床研究,在共变量估计中显示出稳健性.
科学领域:
- 生物统计学 生物统计学
- 生存分析的分析.
- 临床研究方法论 临床研究方法论
背景情况:
- 加速失效时间 (AFT) 模型是考克斯比例危险模型的替代方案.
- AFT模型提供可折叠的效果测量和对生存时间尺度的直接解释.
- 最近的光滑参数 AFT 模型有局限性,需要扩展以更广泛地应用.
研究的目的:
- 增强灵活的参数加速失效时间 (AFT) 模型,以改善临床研究应用.
- 通过引入新功能来解决现有的光滑参数 AFT 模型的局限性.
- 提供一个强大的和可解释的生存分析工具.
主要方法:
- 采用单调的自然线索用于日志累积危险.
- 集成的变时加速度因子和固化模型 (混合和非混合).
- 在公开可用的rstpm2 R包中实现了扩展.
主要成果:
- 模拟显示在估计治愈分数方面具有可变的成功.
- 灵活的AFT模型表现出比Cox模型更强大的协变效应估计的稳定性,即使治疗比例很高.
- 扩展成功地应用于现实世界的生存数据.
结论:
- 开发的灵活的参数 AFT 模型为临床研究中的生存数据分析提供了显著的改进.
- 这些增强的AFT模型为传统的Cox模型提供了更强大和更易于解释的替代方案,特别是在治愈的个体面前.
- rstpm2软件包有助于应用这些先进的 AFT 模型.
相关概念视频
Parametric Survival Analysis: Weibull and Exponential Methods
1.0K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.0K
Assumptions of Survival Analysis
401
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
401
Hazard Rate
404
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
404
Introduction To Survival Analysis
756
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
756
Comparing the Survival Analysis of Two or More Groups
565
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
565
Kaplan-Meier Approach
581
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
581


